Chen Dongfeng is the academic leader of The Research Centre of Integrative Medicine in Guangzhou University of Chinese Medicine. He has his expertise in searching small molecule of Chinese medicine which regulates miRNA. Several patents have been attained in the past few years, such as the application of camphor in the preparation of Chinese medicine for preventing and controlling ischemic stroke. The main direction of recent research is the mechanism of bone marrow mesenchymal stem cells induced chondrogenic differentiation which were regulated with microRNA. The foundation of research is based on basic theory of Chinese medicine combining modern molecular biology techniques.